“…it’s a widely-held belief that a critical element of exceptional R&D organizations in the future will be creative BD engagement. In short, great BD and R&D are becoming synonymous with each other.”
—Bruce Booth, “External Innovation: Force Multiplier for R&D,” Forbes, 6/26/15
“Nearly $26B in real or potentially liquid distributions have been generated over the past two years alone. This is 3-4x more than has been invested over that period of time by VCs into biotech; distributions vastly outstripping investments is certainly positive biomarker for the venture sector.”
—Bruce Booth “Venture-Backed Biotech Today, Reflections on Exits, Funding, and Startup Formation,” Forbes, 1/22/15
